Twist Bioscience Corp (TWST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 09-2020 | 09-2019 | 09-2018 | 09-2017 | 09-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -139,931 | -107,669 | -71,236 | -59,310 | -44,088 |
| Depreciation Amortization | 6,861 | 6,393 | 6,035 | 5,116 | 4,307 |
| Accounts receivable | -14,272 | -6,685 | -3,073 | -1,623 | -702 |
| Accounts payable and accrued liabilities | -5,506 | 3,278 | 3,759 | 560 | 466 |
| Other Working Capital | -25,176 | 2,996 | -4,220 | -129 | 240 |
| Other Operating Activity | 35,769 | 13,750 | 2,571 | 4,085 | 1,185 |
| Operating Cash Flow | $-142,255 | $-87,937 | $-66,164 | $-51,301 | $-38,592 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,868 | -14,736 | -3,671 | -6,328 | -6,229 |
| Net Acquisitions | N/A | N/A | N/A | N/A | 254 |
| Purchase Of Investment | -202,882 | -177,574 | -3,523 | -40,587 | -27,290 |
| Sale Of Investment | 98,100 | 87,500 | 34,500 | 36,925 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -80 |
| Investing Cash Flow | $-114,650 | $-104,810 | $27,306 | $-9,990 | $-33,345 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 2,174 | 7,652 |
| Debt Repayment | -3,333 | -2,500 | 0 | -4,173 | -426 |
| Common Stock Issued | 309,486 | 161,078 | 331 | 205 | 152 |
| Common Stock Repurchased | -2,421 | 0 | N/A | N/A | N/A |
| Other Financing Activity | 0 | 0 | 88,491 | 65,596 | 62,270 |
| Financing Cash Flow | $303,732 | $158,578 | $88,822 | $63,802 | $69,648 |
| Exchange Rate Effect | 21 | 30 | 0 | N/A | N/A |
| Beginning Cash Position | 47,398 | 81,537 | 31,573 | 29,062 | 30,885 |
| End Cash Position | 94,246 | 47,398 | 81,537 | 31,573 | 28,596 |
| Net Cash Flow | $46,848 | $-34,139 | $49,964 | $2,511 | $-2,289 |
| Free Cash Flow | |||||
| Operating Cash Flow | -142,255 | -87,937 | -66,164 | -51,301 | -38,592 |
| Capital Expenditure | -9,868 | -14,757 | -3,688 | -6,594 | -6,229 |
| Free Cash Flow | -152,123 | -102,694 | -69,852 | -57,895 | -44,821 |